Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 230,784 | 200,707 | 148,921 | 81,191 | 71,480 |
| Cost of Goods | 34,102 | 28,533 | 38,509 | 30,428 | 21,891 |
| Gross Profit | 196,682 | 172,174 | 110,412 | 50,763 | 49,589 |
| Operating Expenses | 226,155 | 189,192 | 231,051 | 192,392 | 174,417 |
| Operating Income | -29,371 | -16,485 | -120,130 | -141,201 | -123,937 |
| Interest Expense | 38,901 | 38,757 | 40,762 | 33,546 | 10,223 |
| Other Income | -12,399 | 814 | 1,124 | 3,298 | 1,200 |
| Pre-tax Income | -80,671 | -54,428 | -159,768 | -171,449 | -132,960 |
| Income Tax | 506 | -512 | 2,245 | 406 | 1,018 |
| Net Income Continuous | -81,177 | -53,916 | -162,013 | -171,855 | -133,978 |
| Net Income | $-81,177 | $-53,916 | $-162,013 | $-171,855 | $-133,978 |
| EPS Basic Total Ops | -9.15 | -6.30 | -20.99 | -22.49 | -17.84 |
| EPS Basic Continuous Ops | -9.19 | -6.37 | -20.99 | -22.44 | -17.78 |
| EPS Diluted Total Ops | -9.15 | -6.30 | -20.99 | -22.49 | -17.84 |
| EPS Diluted Continuous Ops | -9.19 | -6.37 | -20.99 | -22.44 | -17.78 |
| EBITDA(a) | $-16,516 | $-3,558 | $-105,855 | $-126,693 | $-108,986 |